BG made an arm's length exit at a 'fair' valuation when the revised clinical strategy resulted in a multi year commercialisation blow out.
JC is imitating this exit at a 'poor' valuation immediately prior to the new clinical strategy materialising because he has no nous, nor imagination.
Going to be painfully obvious in hindsight and I'd be surprised if Biosynergy ever luck themselves into this sort of opportunity ever again.
(Un)fortunately driving the Great Ocean Road today and didn't see much of the price action, but looks to have perfectly bounced of the 65EMA... who says you can't trade illiquid bios?
RAC - Charts & Price Action, page-22496
-
- There are more pages in this discussion • 443 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.55 |
Change
0.085(5.80%) |
Mkt cap ! $264.2M | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.55 | $1.49 | $246.4K | 163.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.55 | 5483 | 2 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |